◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksABBV › Shares Outstanding

AbbVie Inc (ABBV) Shares Outstanding 2009–TTM

DATA UPDATED 2026-08-07

AbbVie Inc annual shares outstanding for fiscal TTM was 1,771 million shares, a decrease of 0.2% from 1,774 million shares in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

ABBV Annual Shares Outstanding

Shares Outstanding (annual)TTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
Shares Outstanding (M)1,771M1,774M1,773M1,773M1,778M1,777M1,673M1,484M1,546M1,603M1,631M1,637M1,610M1,604M1,577M1,625M1,625M1,625M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ABBV Quarterly Shares Outstanding

Shares Outstanding (quarterly)2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Shares Outstanding (M)1,771M1,774M1,774M1,772M1,772M1,772M1,773M1,772M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Shares Outstanding at Comparable Companies

More ABBV metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow

All ABBV financial statements → Interactive ABBV charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.